{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:32Z","timestamp":1786982252264,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/17\/2014-NCD-III)."],"award-info":[{"award-number":["5\/13\/17\/2014-NCD-III)."]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12094-019-02281-x","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T07:02:32Z","timestamp":1583132552000},"page":"1472-1480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome"],"prefix":"10.1007","volume":"22","author":[{"given":"S.","family":"Kashyap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1812-9860","authenticated-orcid":false,"given":"N.","family":"Pushker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"2281_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40487-018-0056-8","volume":"6","author":"M Singh","year":"2018","unstructured":"Singh M, Durairaj P, Yeung J. Uveal melanoma: a review of the literature. Oncol Ther. 2018;6:87\u2013104.","journal-title":"Oncol Ther"},{"key":"2281_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O\u2019Connor","year":"2015","unstructured":"O\u2019Connor MJ. Targeting the DNA damage response in cancer. Mol Cell. 2015;60:547\u201360.","journal-title":"Mol Cell"},{"key":"2281_CR3","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson EDO, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330:1410\u20133.","journal-title":"Science"},{"key":"2281_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01519-6","author":"J Jha","year":"2019","unstructured":"Jha J, Singh MK, Singh L, et al. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors. Int J Clin Oncol. 2019. https:\/\/doi.org\/10.1007\/s10147-019-01519-6.","journal-title":"Int J Clin Oncol"},{"key":"2281_CR5","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1016\/j.febslet.2013.10.035","volume":"587","author":"ZM Eletr","year":"2013","unstructured":"Eletr ZM, Yin L, Wilkinson KD. BAP1 is phosphorylated at serine 592 in S-phase following DNA damage. FEBS Lett. 2013;587:3906\u201311.","journal-title":"FEBS Lett"},{"key":"2281_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ctrv.2013.03.002","volume":"40","author":"E Fokas","year":"2013","unstructured":"Fokas E, Prevo R, Hammond EM, et al. Targeting ATR in DNA damage response and cancer therapeutics. Cancer Treat Rev. 2013;40:109\u201317.","journal-title":"Cancer Treat Rev"},{"key":"2281_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1158\/1541-7786.MCR-14-0240","volume":"13","author":"DL Menezes","year":"2015","unstructured":"Menezes DL, Holt J, Tang Y, et al. A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function. Mol Cancer Res. 2015;13:120\u20139.","journal-title":"Mol Cancer Res"},{"key":"2281_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ajhg.2012.01.007","volume":"90","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Weine S, Nagy N, et al. Germline mutation in ATR in autosomal-dominant oropharyngeal cancer syndrome. AJHG. 2012;90:511\u20137.","journal-title":"AJHG"},{"key":"2281_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/(SICI)1098-2264(199910)26:2<176::AID-GCC11>3.0.CO;2-3","volume":"26","author":"F Bertoni","year":"1999","unstructured":"Bertoni F, Codegoni AM, Furlan D, et al. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes Chromosomes Cancer. 1999;26:176\u201380.","journal-title":"Genes Chromosomes Cancer"},{"key":"2281_CR10","first-page":"7727","volume":"61","author":"A Menoyo","year":"2001","unstructured":"Menoyo A, Alazzouzi H, Esp\u00edn E, et al. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res. 2001;61:7727\u201330.","journal-title":"Cancer Res"},{"key":"2281_CR11","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1158\/0008-5472.CAN-05-1019","volume":"65","author":"KA Lewis","year":"2005","unstructured":"Lewis KA, Mullany S, Thomas B, et al. Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance. Cancer Res. 2005;65:7091\u20135.","journal-title":"Cancer Res"},{"key":"2281_CR12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","volume":"98","author":"TH van Essen","year":"2014","unstructured":"van Essen TH, van Pelt SI, Versluis M, et al. Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br J Ophthalmol. 2014;98:1738\u201343.","journal-title":"Br J Ophthalmol"},{"key":"2281_CR13","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.celrep.2017.02.040","volume":"18","author":"CF Chen","year":"2017","unstructured":"Chen CF, Ruiz-Vega R, Vasudeva P, et al. ATR mutations promote the growth of melanoma tumors by modulating the immune microenvironment. Cell Rep. 2017;18:2331\u201342.","journal-title":"Cell Rep"},{"key":"2281_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","volume":"127","author":"CL Shields","year":"2009","unstructured":"Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989\u201398.","journal-title":"Arch Ophthalmol"},{"key":"2281_CR15","doi-asserted-by":"publisher","first-page":"9717","DOI":"10.1007\/s13277-015-3735-1","volume":"36","author":"MG Diniz","year":"2015","unstructured":"Diniz MG, Silva Jde F, de Souza FT, et al. Association between cell cycle gene transcription and tumor size in oral squamous cell carcinoma. Tumour Biol. 2015;36:9717\u201322.","journal-title":"Tumour Biol"},{"key":"2281_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00008390-200106000-00007","volume":"11","author":"AD Singh","year":"2001","unstructured":"Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res. 2001;11:255\u201363.","journal-title":"Melanoma Res"},{"key":"2281_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.1977.04450010050004","volume":"95","author":"MJ McLean","year":"1977","unstructured":"McLean MJ, Foster WD, Zimmerman LE. Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol. 1977;95:48\u201358.","journal-title":"Arch Ophthalmol"},{"key":"2281_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/1097-0142(19900101)65:1<112::AID-CNCR2820650123>3.0.CO;2-X","volume":"65","author":"PO de la Cruz","year":"1990","unstructured":"de la Cruz PO, Jr Specht CS, McLean IW. Lymphocytic infiltration in uveal malignant melanoma. Cancer. 1990;65:112\u20135.","journal-title":"Cancer"},{"key":"2281_CR19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0161-6420(93)31470-3","volume":"100","author":"R Folberg","year":"1993","unstructured":"Folberg R, Rummelt V, Parys-Van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100:1389\u201398.","journal-title":"Ophthalmology"},{"key":"2281_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/BF02159979","volume":"219","author":"K Bujara","year":"1982","unstructured":"Bujara K. Necrotic malignant melanomas of the choroid and ciliary body. A clinicopathological and statistical study. Graefes Arch Clin Exp Ophthalmol. 1982;219:40\u20133.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2281_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00418-008-0530-8","volume":"130","author":"G Lorusso","year":"2008","unstructured":"Lorusso G, R\u00fcegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol. 2008;130:1091\u2013103.","journal-title":"Histochem Cell Biol"},{"key":"2281_CR22","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2008.19.9802","volume":"27","author":"I Zighelboim","year":"2009","unstructured":"Zighelboim I, Schmidt AP, Gao F, et al. ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes. J Clin Oncol. 2009;27:3091\u20136.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-019-02281-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02281-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T20:06:16Z","timestamp":1614629176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-019-02281-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1007\/s12094-019-02281-x","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed after the approval from the Institutional Ethics Committee (IEC), All India Institute of Medical Sciences (IEC\/NP-177\/05.06.2014). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional ethical committee of AIIMS and with the Helsinki declaration and comparable with ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}